Cargando…
Ingestion of milk containing the Dp2 peptide, a dust mite allergen, protects mice from allergic airway inflammation and hyper-responsiveness
BACKGROUND: Allergen-specific immunotherapy has been demonstrated to have potential for the treatment of allergic diseases. Transgenic animals are currently the best available bioreactors to produce recombinant proteins, which can be secreted in milk. It has not been clearly demonstrated whether mil...
Autores principales: | Liu, Hsu-Chung, Pai, Shun-Yuan, Cheng, Winston TK, Chen, Hsiao-Ling, Tsai, Tung-Chou, Yang, Shang-Hsun, Chen, Chuan-Mu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3689609/ https://www.ncbi.nlm.nih.gov/pubmed/23763898 http://dx.doi.org/10.1186/1710-1492-9-21 |
Ejemplares similares
-
Oral immunotherapy with the ingestion of house dust mite extract in a murine model of allergic asthma
por: Wang, Yao-Tung, et al.
Publicado: (2018) -
β-Glucan exacerbates allergic airway responses to house dust mite allergen
por: Hadebe, Sabelo, et al.
Publicado: (2016) -
Sublingual immunotherapy (SLIT) for house dust mites does not prevent new allergen sensitization and bronchial hyper-responsiveness in allergic rhinitis children
por: Lim, Jae Hyun, et al.
Publicado: (2017) -
Immunotherapy – 2077. Allergen specific immunotherapy in allergic conjuntivitis due to dust mite
por: Pawar, Sanjay
Publicado: (2013) -
Role of proteinase-activated receptor-2 in allergic sensitization to house dust mite allergens
por: Davidson, Courtney, et al.
Publicado: (2011)